In a recent Contemporary Clinical Trials commentary, University of Illinois Chicago researchers and colleagues explain how embedded pragmatic clinical trials, or ePCTs, which test the effectiveness of medical interventions in real-world settings, potentially leave out people who are from underrepresented and underserved groups.